01 1CKD BIO Corp. Ansan Factory
02 3CKD Bio Corporation
03 4Fermic, s.a. de c.v.
04 2Lek d.d.
05 2Shandong New Time Pharmaceutical Co., Ltd.
06 1Sinopharm Weiqida Datong Pharmaceutical Co., Ltd.
07 1Sinopharm Weiqida Pharmaceutical Co., Ltd.
01 8CLAVULANATE POTASSIUM
02 4Clavulanate Potassium
03 1Clavulanate Potassium diluted with Microcrystalline Cellulose
04 1Clavulanate Potassium diluted with Silicon Dioxide
01 4China
02 4Mexico
03 2Slovenia
04 4South Korea
NDC Package Code : 52972-0031
Start Marketing Date : 2003-02-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52972-0033
Start Marketing Date : 2005-06-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 39390-0043
Start Marketing Date : 2018-11-23
End Marketing Date : 2028-01-13
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39390-0044
Start Marketing Date : 2018-11-23
End Marketing Date : 2028-01-13
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39390-0045
Start Marketing Date : 2024-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39390-0046
Start Marketing Date : 2024-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48866-9981
Start Marketing Date : 2022-11-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 48866-9982
Start Marketing Date : 2022-11-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 42677-104
Start Marketing Date : 2007-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 42677-105
Start Marketing Date : 2007-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Potassium Clavulanate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Potassium Clavulanate, including repackagers and relabelers. The FDA regulates Potassium Clavulanate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Potassium Clavulanate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Potassium Clavulanate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Potassium Clavulanate supplier is an individual or a company that provides Potassium Clavulanate active pharmaceutical ingredient (API) or Potassium Clavulanate finished formulations upon request. The Potassium Clavulanate suppliers may include Potassium Clavulanate API manufacturers, exporters, distributors and traders.
click here to find a list of Potassium Clavulanate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Potassium Clavulanate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Potassium Clavulanate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Potassium Clavulanate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Potassium Clavulanate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Potassium Clavulanate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Potassium Clavulanate suppliers with NDC on PharmaCompass.
We have 6 companies offering Potassium Clavulanate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
